LENZ THERAPEUTICS, INC.

Company

LENZ Therapeutics, Inc.

Filed

March 28, 2024

Accession Number

0000902664-24-002661

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →